Showing results (161-170 of 1,268) with videos related to
Sort By:
Pageof 127
Biostatistics (Oxford, England)|October 13, 2006
Screening designs for drug developmentDavid Rossell, Peter Müller, Gary L RosnerBiometrics|September 4, 2007
Determining the effective sample size of a parametric priorSatoshi Morita, Peter F Thall, Peter MüllerSeminars in Cancer Biology|October 6, 2020
Innovative trial design in precision oncologyApostolia M Tsimberidou, Peter Müller, Yuan JiJournal of Computational and Graphical Statistics : a Joint Publication of American Statistical Association, Institute of Mathematical Statistics, Interface Foundation of North America|October 5, 2020
A Semiparametric Bayesian Approach to Dropout in Longitudinal Studies with Auxiliary CovariatesTianjian Zhou, Michael J Daniels, Peter MüllerNeuroreport|April 4, 2002
The effects of the neuroactive steroid 3 alpha,5 alpha-THDOC on sleep in the ratPeter Müller-Preuss, Rainer Rupprecht, Marike LancelFrontiers in Molecular Biosciences|August 28, 2020
Intermolecular Communication in Bacillus subtilis: RNA-RNA, RNA-Protein and Small Protein-Protein InteractionsInam Ul Haq, Peter Müller, Sabine BrantlMolecular Microbiology|November 23, 2023
A comprehensive study of the interactions in the B. subtilis degradosome with special emphasis on the role of the small proteins SR1P and SR7PInam Ul Haq, Peter Müller, Sabine BrantlBreast Cancer Research and Treatment|September 17, 2020
Oncotype DX testing in node-positive breast cancer strongly impacts chemotherapy use at a comprehensive cancer centerKatya Losk, Rachel A Freedman, Alison Laws, et al.Neuro-Oncology|March 9, 2018
The clinical trials landscape for glioblastoma: is it adequate to develop new treatments?Alyssa M Vanderbeek, Rifaquat Rahman, Geoffrey Fell, et al.The New England Journal of Medicine|June 21, 2024
Brigatinib in NF2-Related Schwannomatosis with Progressive TumorsScott R Plotkin, Kaleb H Yohay, Phioanh L Nghiemphu, et al.Pageof 127